Table 2.
Year | CMS | N | Age | FU | SR | PS | CR | |
---|---|---|---|---|---|---|---|---|
Open peritendineous debridement | ||||||||
Nelen et al. [24]a | 1989 | 66 | 93 | n.s. | n.s. | 88 | n.s. | n.s. |
Paavola et al. [18] | 2002 | 59 | 16 | 37 | 7 | 100 | 94 | 6 |
62.5 ± 4.9 | 109 | 37 | 7 | 89.8 ± 8.5 | 94 | 6 | ||
Open intratendineous debridement | ||||||||
Nelen et al. [24]a | 1989 | 66 | 26 | n.s. | n.s. | 73 | n.s. | n.s. |
Alfredson et al. [19] | 2007 | 53 | 10 | 45 | 6 | 100 | 80 | 10 |
Lohrer & Nauck [32] | 2014 | 81 | 34 | 50 | 12 | 97 | n.s. | 8 |
Paavola et al. [18] | 2002 | 59 | 26 | 46 | 7 | 73 | 79 | 27 |
64.8 ± 12.1 | 96 | 47.8 ± 2.6 | 6.8 ± 4.9 | 84.3 ± 14.8 | 79.3 ± 0.7 | 15.3 ± 10.4 | ||
FHL transfer/augmentation | ||||||||
Nelen et al. [24] | 1989 | 66 | 24 | n.s. | n.s. | 87 | n.s. | n.s. |
Cottom et al. [29] | 2008 | 81 | 62 | 61 | 27 | n.s. | 95 | 23 |
Wilcox et al. [41] | 2000 | 58 | 17 | 61 | 14 | 75 | n.s. | 0 |
Martin et al. [37] | 2005 | 84 | 44 | 58 | 41 | 91 | 86 | 11 |
Lui et al. [33] | 2012 | 69 | 5 | 46 | 20 | 80 | n.s. | 0 |
71.6 ± 10.8 | 152 | 59.4 ± 7.1 | 29.8 ± 11.6 | 86.3 ± 7.1 | 91.3 ± 6.4 | 14.9 ± 11.0 | ||
Gastrocnemius recession | ||||||||
Duthon et al. [30] | 2011 | 64 | 14 | 42 | 24 | 79 | 60 | 0 |
Gurdezi et al. [31] | 2013 | 70 | 5 | 45 | 30 | n.s. | 66 | n.s. |
67.0 ± 4.2 | 19 | 42.8 ± 2.1 | 25.6 ± 4.2 | 79.0 | 61.6 ± 4.2 | 0.0 | ||
Percutaneous longitudinal tenotomy | ||||||||
Alfredson et al. [25] | 2011 | 73 | 87 | 46 | 18 | 83 | 83 | 3 |
Maffulli et al. [28] | 2013 | 84 | 39 | 45 | 204 | 77 | 77 | 18 |
78.5 ± 7.8 | 126 | 45.7 ± 0.7 | 75.6 ± 131.6 | 81.1 ± 4.2 | 81.1 ± 4.2 | 7.6 ± 10.6 | ||
Minimally invasive paratenon debridement | ||||||||
Maquirriain et al. [42] | 2013 | 79 | 24 | 46 | 92 | 100 | n.s. | 7 |
Pearce et al. [26] | 2012 | 62 | 11 | 37 | 30 | n.s. | 72 | 0 |
Vega et al. [40] | 2008 | 69 | 8 | 43 | 27 | 100 | n.s. | 0 |
Alfredson et al. [25] | 2011 | 73 | 16 | 47 | 18 | 74 | 74 | 3 |
Ruergård & Alfredson [38] | 2014 | 79 | 47 | 52 | 12 | n.s. | 88 | 0 |
72.4 ± 7.2 | 106 | 47.7 ± 5.5 | 34.0 ± 32.2. | 91.3 ± 15.0 | 82.6 ± 8.7 | 2.0 ± 3.1 |
Year of publication (Year), Coleman Methodological Score (CMS), Number of patients (N), aFor this study N means number of tendons, Age (years), Followup period (FU) in months, Success rate (SR) in %, Patient satisfaction (PS) in %, and Complication rates (CR) in %. Values for FU, SR, and PS of the individual studies are presented as means. Summarized information of the specific operative techniques are presented in the last lines of the respective sections (CMS = unweighted mean. Age, FU, SR, PS, and CR = weighted means ± SD)